Skip to main content
Figure 4 | Journal of Experimental & Clinical Cancer Research

Figure 4

From: Superiority and clinical significance of Lunx mRNA in the diagnosis of malignant pleural effusion caused by pulmonary carcinoma

Figure 4

Lunx mRNA expression in the pleural fluid before and after the first chemotherapy session. Pleural fluid samples from 82 patients were collected before and after treatment and divided into the CR, PR, NC, and PD groups. Copy numbers less than 103 copies/ml were considered negative. When the copy number of Lunx mRNA was not detectable, the results were shown as number undetected. CR: complete remission, n = 12; PR: partial remission, n = 48; NC: no change, n = 10; PD: progressive disease, n = 12.

Back to article page